Switzerland to India Pharmaceutical Import
Bilateral Trade Intelligence · $71.2M Total Trade · 113 Foreign Suppliers · 80 Indian Buyers · DGFT Verified · Updated March 2026
India imported $71.2M worth of pharmaceutical formulations from Switzerland across 1,111 verified shipments, from 113 foreign suppliers to 80 Indian buyers. The top suppliers are ELI LILLY EXPORT S.A ($13.6M) and TAKEDA PHARMACEUTICALS INTERNATIONAL AG. ($8.9M). The leading products are Insulin ($15.6M) and Serum ($8.9M). Average shipment value: $64.1K.
Top Pharmaceutical Formulations — Switzerland to India
| # | Formulation | Value | Share |
|---|---|---|---|
| 1 | Insulin | $15.6M | 21.9% |
| 2 | Serum | $8.9M | 12.6% |
| 3 | Collagen | $5.5M | 7.7% |
| 4 | Trastuzumab | $5.4M | 7.6% |
| 5 | Meropenem | $5.0M | 7.1% |
| 6 | Daratumumab | $4.1M | 5.8% |
| 7 | Ibrutinib | $3.8M | 5.3% |
| 8 | Prednisone | $3.7M | 5.1% |
| 9 | Everolimus | $2.8M | 3.9% |
| 10 | Bevacizumab | $2.0M | 2.8% |
| 11 | Valsartan | $1.9M | 2.7% |
| 12 | Moxifloxacin | $1.5M | 2.1% |
| 13 | Mycophenolate | $1.3M | 1.9% |
| 14 | Lenalidomide | $1.3M | 1.9% |
| 15 | Ustekinumab | $1.0M | 1.5% |
India imports 20+ pharmaceutical formulations from Switzerland with a combined trade value of $71.2M. Key products include Insulin ($15.6M), Serum ($8.9M), Collagen ($5.5M), Trastuzumab ($5.4M), Meropenem ($5.0M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 1,111 verified Indian Customs (DGFT) shipment records.
Top Pharmaceutical Products — Switzerland to India Trade Routes
These are the top pharmaceutical products exported from India to Switzerland, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Switzerland buyers, regulatory requirements, and logistics for that specific product corridor. Products include Insulin ($15.6M), Serum ($8.9M), Collagen ($5.5M), Trastuzumab ($5.4M), Meropenem ($5.0M) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.
Top Switzerland Suppliers to India
113 Indian pharmaceutical companies export finished formulations to Switzerland. Leading exporters include Eli Lilly Export S.a, Takeda Pharmaceuticals International Ag., Novartis Pharma Ag, Geistlich Pharma Ag. The top exporter accounts for 19.1% of total India–Switzerland pharma exports. Source: Indian Customs (DGFT).
Top Indian Buyers from Switzerland
80 companies in Switzerland import pharmaceutical formulations from India. Top buyers include Eli Lilly And Company (india ) Private Limited, Novartis Healthcare Private Limited, Roche Products (india) Private Limited, Takeda Biopharmaceuticals India Private Limited. The largest buyer accounts for 22.1% of India–Switzerland pharma imports. Source: Indian Customs (DGFT).
Trade Statistics
Other Import Origins
Product Routes
FAQ — India to Switzerland Pharmaceutical Trade
What is the total value of India's pharmaceutical export to Switzerland?
India exported pharmaceuticals worth $71.2M to Switzerland across 1,111 verified shipments.
Who are the top Indian pharmaceutical exporters to Switzerland?
1. ELI LILLY EXPORT S.A — $13.6M. 2. TAKEDA PHARMACEUTICALS INTERNATIONAL AG. — $8.9M. 3. NOVARTIS PHARMA AG — $7.6M. Total: 113 suppliers.
Which companies in Switzerland import pharmaceuticals from India?
1. ELI LILLY AND COMPANY (INDIA ) PRIVATE LIMITED — $15.7M. 2. NOVARTIS HEALTHCARE PRIVATE LIMITED — $10.6M. 3. ROCHE PRODUCTS (INDIA) PRIVATE LIMITED — $9.1M. 80 buyers total.
What pharmaceutical products does India export most to Switzerland?
1. Insulin ($15.6M, 21.9%); 2. Serum ($8.9M, 12.6%); 3. Collagen ($5.5M, 7.7%); 4. Trastuzumab ($5.4M, 7.6%); 5. Meropenem ($5.0M, 7.1%)
Which ports handle pharmaceutical shipments from India to Switzerland?
Export: . Import: .
Why does Switzerland import pharmaceuticals from India?
India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $71.2M corridor reflects quality compliance and pricing advantages.
What certifications do Indian pharmaceutical exporters need to supply Switzerland?
WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.
What is the average shipment value for India to Switzerland pharmaceutical trade?
$64.1K per consignment across 1,111 shipments.
How many Indian pharmaceutical companies export to Switzerland?
113 Indian companies. Largest: ELI LILLY EXPORT S.A with $13.6M.
How can I find verified Indian pharmaceutical suppliers for Switzerland?
TransData Nexus covers 113 active exporters with shipment history and trade values at transdatanexus.com.
Unlock the Full India to Switzerland Pharmaceutical Export Dataset
Access complete shipment records, supplier intelligence, buyer histories, and price analytics for all 1,111 shipments.
Official References & Regulatory Resources
- WHO Essential Medicines List
- CDSCO India
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
- 2.Country Matching: Shipments to Switzerland identified using destination country codes from customs declarations.
- 3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
- 4.Coverage: 1,111 verified shipments from 113 Indian exporters to 80 Switzerland buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
113 Exporters
80 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists